Precio de cierre
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
8.580 KRW | -0,58 % | +0,23 % | -16,46 % |
Resumen de negocios
Número de empleados: 810
Ventas por actividad
KRW en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceutical
92,8
%
| 315 928 | 92,8 % | 335 135 | 92,8 % | +6,08 % |
Medical Equipment
7,4
%
| 24 614 | 7,2 % | 26 561 | 7,4 % | +7,91 % |
Consolidated Adjustment
-0,2
%
| -116 | 0,0 % | -587 | -0,2 % | +406,78 % |
Ventas por región
KRW en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
South Korea
95,0
%
| 321 926 | 94,6 % | 342 936 | 95,0 % | +6,53 % |
Overseas
5,0
%
| 18 501 | 5,4 % | 18 173 | 5,0 % | -1,77 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Jun-Ha Yoo
CEO | Chief Executive Officer | 60 | - |
Ma-Se Lee
CTO | Chief Tech/Sci/R&D Officer | 61 | - |
Dae-Hyun Kim
BRD | Director/Board Member | 47 | - |
In-Ho Yoon
BRD | Director/Board Member | 40 | - |
Hyun-Gyeong Yoon
PRN | Corporate Officer/Principal | 44 | - |
Do-Joon Yoon
PRN | Corporate Officer/Principal | 72 | - |
Gil-Joon Yoon
PRN | Corporate Officer/Principal | 67 | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Do-Joon Yoon
PRN | Corporate Officer/Principal | 72 | - |
In-Ho Yoon
BRD | Director/Board Member | 40 | - |
Sem-An Oh
BRD | Director/Board Member | 68 | 21/03/19 |
Jun-Ha Yoo
CEO | Chief Executive Officer | 60 | - |
Gwang-Jun Kim
BRD | Director/Board Member | 47 | 19/03/20 |
Na-Na Geum
BRD | Director/Board Member | 41 | 19/03/20 |
Dae-Hyun Kim
BRD | Director/Board Member | 47 | - |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 27 931 470 | 17 249 808 ( 61,76 %) | 213 540 ( 0,7645 %) | 61,76 % |
Participaciones
Nombre | Acciones | % | Valoración |
---|---|---|---|
WHAN IN PHARM CO.,LTD. 1.88% | 350 000 | 1.88% | 3 580 784 $ |
DONGWHA PHARM.CO.,LTD 0.90% | 252 340 | 0.90% | 1 592 074 $ |
JETEMA, CO., LTD. 0.62% | 110 000 | 0.62% | 1 244 772 $ |
GENEXINE, INC. 0.22% | 90 013 | 0.22% | 489 109 $ |
Información de la empresa
DONG WHA PHARM Co., Ltd.
6-8/F, FastFive Tower 24 Namdaemun-ro 9-gil
04522, Seoul
+
http://www.dong-wha.co.krSector
Ventas por actividad
Ventas por región
Varia. 1 de ene. | Capi. | |
---|---|---|
-16,46 % | 175 M | |
+22,36 % | 44,12 mil M | |
+22,22 % | 22,61 mil M | |
+18,00 % | 15,11 mil M | |
+14,36 % | 13,61 mil M | |
+61,27 % | 13,34 mil M | |
-8,98 % | 6939,55 M | |
-0,05 % | 6787,61 M | |
-8,87 % | 5725,52 M | |
+15,65 % | 5751,97 M |
- Bolsa de valores
- Acciones
- Acción A000020
- Empresa Dongwha Pharm.Co.,Ltd